Emerging Technologies in GPCR-Based Drug Target Receptors (Technical Insights)

 

Regular Price: USD 4,950

Special Price USD 3,465

30% OFF

* Required Fields

Regular Price: USD 4,950

Special Price USD 3,465

PAY BY INVOICE

Be the first to review this product

This research service outlines the technologies for GPCR Drug Discovery.

Table of Contents

Emerging Technologies in GPCR-Based Drug Target Receptors (Technical Insights), Executive SummaryResearch Overview and HighlightsGPCRs: Versatility Unparalleled Yet Potential UntappedKey Highlights of the Research Service Scope and MethodologyScope and Segmentation MethodologyEmerging Technologies in GPCR-Based Drug Target Receptors (Technical Insights), Technology Primer and Adoption FactorsTechnology PrimerThe Process of Signal Transduction--A SnapshotBiology and Classification of GPCRsCell-Based Assays for GPCRsCell-Based Assays--An IntroductionApplications of Cell-Based AssaysEmerging Technologies in GPCR-Based Drug Target Receptors (Technical Insights), Key Developments in the GPCR SpaceDevelopments across the IndustryDeveloping Next Generation Drugs Using GPCR-HITGPCR Dimer Identification Technology GPCR Compound Libraries for Low Molecular Weight and Drug-Like Molecules Nanobody Platform for GPCRsNovel Peptide Ligand Discovery for GPCRsNovel High-Throughput Assay for GPCRsHigh-Expression Mammalian Cell Lines Aide in Targeting GPCR Proteins Small Molecule Libraries for GPCRs - NCEsNovel Assay Uses Protein-Fragment Complementation to Screen GPCRs and Other Targets in Their Native Cellular ContextPersonalized Assay Services for GPCRsIslet Therapy for Metabolic DiseasesProtein Mimicry Technology for GPCRsDevelopments across AcademiaResearchers Use NMR to Determine the Structure of Membrane ProteinsGPCR Screening Reveals Receptors Involved in Neuronal ProtectionEmerging Technologies in GPCR-Based Drug Target Receptors (Technical Insights), Technology Analysis and Adoption FactorsForce Field Analysis--Drug Discovery for GPCRsGrowth Accelerators Technology BarriersStrategic Analysis of the Industry--Cell Based Assays for GPCRsPorter's Analysis for the Cell-Based Assays IndustryStrategic Recommendations for the IndustryEmerging Technologies in GPCR-Based Drug Target Receptors (Technical Insights), Patents and Key ParticipantsList of PatentsPatents across the IndustryPatents across AcademiaKey ParticipantsIndustry ParticipantsAcademic ParticipantsEmerging Technologies in GPCR-Based Drug Target Receptors (Technical Insights), Decision Support DatabaseDSD TablesNumber of Biotech Companies (Million USD)--World (2004 to 2014)Percentage Pharmaceutical R&D Expenditure (Million USD)--World (2004 to 2014)Pharmaceutical Market (Million USD)--World (2004 to 2014)Venture Capital Investment in Biotech R&D (Million USD)--World (2004 to 2014)




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 08-Dec-17

Region : Global

Release Date : 08-Dec-17

Region : Global

Release Date : 01-Dec-17

Region : Global

Release Date : 29-Nov-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.